Medications

FDA: Asthma drug Singulair to get 'black box' warning

Asthma and allergy drug montelukast—sold as a generic and under the brand name Singulair—will get a "boxed warning" over potential ties to neuropsychiatric effects, the U.S. Food and Drug Administration announced Wednesday.

page 4 from 40